Collegium Pharmaceutical Inc (COLL)
Payables turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 399,806 | 426,631 | 316,970 | 304,692 | 324,861 |
| Payables | US$ in thousands | 8,692 | 3,494 | 4,189 | 10,016 | 6,247 |
| Payables turnover | 46.00 | 122.10 | 75.67 | 30.42 | 52.00 |
December 31, 2023 calculation
Payables turnover = Cost of revenue ÷ Payables
= $399,806K ÷ $8,692K
= 46.00
The payables turnover ratio for Collegium Pharmaceutical Inc has fluctuated over the past five years. In 2023, the payables turnover ratio was 10.91, indicating the company is paying its suppliers approximately 10.91 times a year on average. This ratio is lower compared to the previous year (33.83 in 2022), suggesting a longer payment cycle for the company in 2023. However, it is still higher than the ratios reported in 2021 (14.10), 2020 (6.94), and 2019 (31.00), indicating an improvement in payables turnover efficiency in 2023 compared to those years. Overall, the trend in payables turnover ratios for Collegium Pharmaceutical Inc shows variability but an improvement in managing supplier payments in 2023 compared to earlier years.
Peer comparison
Dec 31, 2023